Adagene prices $70 million public offering at $3.75 per ADS
#Adagene #public offering #$70 million #$3.75 per ADS #capital raising #biotech #stock offering #pharmaceuticals
📌 Key Takeaways
- Adagene priced a $70 million public offering at $3.75 per ADS
- The offering aims to raise capital for the company's operations
- The pricing reflects current market valuation and investor demand
- Proceeds will support Adagene's biotech research and development initiatives
🏷️ Themes
Finance, Biotechnology
Entity Intersection Graph
No entity connections available yet for this article.